HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrea L Cox Selected Research
Andrea L Cox Research Topics
Disease
53
Infections
06/2022 - 04/2005
20
COVID-19
10/2022 - 10/2020
9
Hepatitis C
01/2022 - 05/2012
8
Persistent Infection
01/2022 - 07/2005
8
Virus Diseases (Viral Diseases)
08/2021 - 11/2008
8
Viremia
01/2017 - 04/2005
7
Reinfection
01/2022 - 01/2010
4
Neoplasms (Cancer)
06/2022 - 02/2012
4
Inflammation (Inflammations)
01/2022 - 05/2014
4
Breakthrough Infections
01/2022 - 10/2021
3
Hepatocellular Carcinoma (Hepatoma)
01/2019 - 07/2014
3
HIV Infections (HIV Infection)
01/2017 - 03/2007
2
Communicable Diseases (Infectious Diseases)
01/2022 - 08/2021
2
Disease Progression
01/2022 - 09/2016
2
Human Influenza (Influenza)
01/2022 - 10/2020
2
Chronic Hepatitis C
11/2021 - 09/2015
2
Fever (Fevers)
06/2021 - 03/2021
1
Common Cold
06/2022
1
Hypersensitivity (Allergy)
01/2022
1
Coronavirus Infections
01/2022
1
Dengue (Dengue Fever)
01/2022
1
Lung Diseases (Lung Disease)
01/2022
1
Thrombosis (Thrombus)
01/2022
1
Zika Virus Infection
01/2022
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1
Vaccinia
11/2021
1
Atherosclerosis
08/2021
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1
Melanoma (Melanoma, Malignant)
01/2020
1
Encephalitis (Encephalitis, Rasmussen)
01/2020
Drug/Important Bio-Agent (IBA)
23
Vaccines
IBA
10/2022 - 07/2010
17
RNA (Ribonucleic Acid)
IBA
11/2021 - 04/2005
11
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2016
11
Antibodies
IBA
01/2022 - 07/2008
9
Antigens
IBA
06/2022 - 07/2005
9
Epitopes
IBA
01/2019 - 06/2005
7
Broadly Neutralizing Antibodies
IBA
01/2022 - 06/2014
7
Neutralizing Antibodies
IBA
01/2022 - 06/2009
6
Immunoglobulin G (IgG)
IBA
01/2022 - 07/2008
5
Glycoproteins (Glycoprotein)
IBA
06/2022 - 06/2009
4
Interferons
IBA
01/2022 - 12/2011
4
Peptides (Polypeptides)
IBA
01/2022 - 07/2005
4
Cytokines
IBA
01/2022 - 12/2016
4
Interleukin-18 (Interleukin 18)
IBA
01/2022 - 12/2011
4
Pharmaceutical Preparations
IBA
11/2021 - 04/2005
4
Antiviral Agents (Antivirals)
IBA
03/2021 - 05/2014
4
Interferon Lambda
IBA
12/2020 - 11/2014
3
mRNA Vaccines
IBA
06/2022 - 01/2022
3
Autoantibodies
IBA
01/2022 - 10/2020
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 08/2016
3
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 12/2011
3
Chemokines
IBA
01/2022 - 01/2021
3
Immunoglobulin M (IgM)
IBA
01/2022 - 07/2008
3
Viral RNA
IBA
06/2021 - 06/2012
3
Inflammasomes
IBA
01/2020 - 05/2014
2
Messenger RNA (mRNA)
IBA
10/2022 - 06/2022
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
06/2022 - 01/2021
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022 - 12/2011
2
COVID-19 Vaccines
IBA
01/2022 - 01/2022
2
Interferon-gamma (Interferon, gamma)
IBA
01/2020 - 07/2005
2
Nucleotides
IBA
01/2020 - 05/2012
2
Biological Products
IBA
01/2018 - 12/2013
2
Interleukin-12 (IL 12)
IBA
01/2017 - 12/2011
2
Interleukins
IBA
01/2017 - 06/2012
2
Alanine Transaminase (SGPT)
IBA
12/2011 - 04/2005
2
T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
IBA
11/2008 - 06/2005
2
Polyproteins
IBA
07/2005 - 06/2005
1
Interleukin-15 (Interleukin 15)
IBA
01/2022
1
von Willebrand Factor
IBA
01/2022
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
01/2022
1
fibrin fragment D (D-dimer)
IBA
01/2022
1
Amino Acids
FDA Link
01/2022
1
Interleukin-10 (Interleukin 10)
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
P-Selectin
IBA
01/2022
1
Selectins
IBA
01/2022
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2022
1
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2022
1
Chemokine CCL8
IBA
01/2022
1
Angiotensin-Converting Enzyme 2
IBA
01/2022
1
Oxygen (Dioxygen)
IBA
01/2022
1
Cholesterol
IBA
08/2021
1
Branched-Chain Amino Acids
IBA
08/2021
1
Lipoproteins (Lipoprotein)
IBA
08/2021
1
HDL Cholesterol
IBA
08/2021
1
LDL Cholesterol
IBA
08/2021
1
Triglycerides (Triacylglycerol)
IBA
08/2021
1
3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)
IBA
08/2021
1
Anti-Retroviral Agents (Antiretroviral Agents)
IBA
03/2021
1
DNA (Deoxyribonucleic Acid)
IBA
03/2021
1
Ligands
IBA
01/2021
1
Voltage-Dependent Anion Channel 1
IBA
01/2021
1
Angiotensins
IBA
10/2020
1
Hexokinase
IBA
10/2020
1
Voltage-Dependent Anion Channels
IBA
10/2020
1
Opioid Analgesics (Opioids)
IBA
01/2020
1
Leucine (L-Leucine)
FDA Link
01/2020
Therapy/Procedure
2
Immunotherapy
06/2022 - 01/2021
1
Cannula
01/2022
1
Artificial Respiration (Mechanical Ventilation)
01/2022